Replies to post #1830 on Revance Therapeutics Inc (RVNC)

[valiano]

Thanks for your reply. My estimate for 2021 filler sales is in the same ballpark.

It's also IMO a good thing that the sales force won't be idle during this time. Establishing aesthetic practice accounts from now should set the stage for a faster Daxi ramp.